在胃肠病学中使用电药和磁药
Gengqing Song1, Roberta Sclocco2,3, Amol Sharma4
1Division of Gastroenterology & Hepatology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH 44109, USA.
Biomolecules
|July 27, 2024
概括
神经调节技术,如神经刺激和针,为胃肠 (GI) 运动障碍和炎症性肠病 (IBD) 提供了有希望的替代方案. 这些方法针对神经系统来改善胃肠道功能和减少炎症,解决当前治疗方法的局限性.
科学领域:
- 胃肠病学 胃肠病学
- 神经胃肠病学 神经胃肠病学
- 翻译医学是一种翻译医学.
背景情况:
- 目前用于胃肠道 (GI) 运动障碍和炎症性肠病 (IBD) 的治疗方法往往不足,可能会导致副作用.
- 对于管理这些复杂的胃肠道疾病而言,急需新的治疗策略.
研究的目的:
- 审查神经调节技术的潜力,作为消化道运动障碍和IBD的替代疗法.
- 探索神经刺激 (VNS),磁性神经调节和针在治疗这些疾病中的有效性.
主要方法:
- 对胃肠病学中神经调节现有文献的综述.
- 对研究VNS,磁性神经调节和针治疗胃肠道运动和炎症的研究进行分析.
主要成果:
- 阴道神经刺激 (VNS) 证明了针对性调节肠道运动和炎症.
- 磁性神经调节显示了对神经生理过程的非侵入性增强的承诺,改善了胃肠道功能.
- 针和电针表现出全面的神经免疫内分泌作用,缓解胃肠道运动和炎症症状.
结论:
- 神经调节为肠道运动障碍和IBD提供了一个有前途的治疗途径.
- 需要进一步的研究来优化这些干预措施,并制定针对患者的治疗策略.
- 这些新的方法可能会在治疗具有挑战性的胃肠道疾病方面建立一个新的范式.
相关概念视频
Peptic Ulcer Disease IV: Management
79
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
79
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
384
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
384
Gastroesophageal Reflux Disease II: Clinical Features and Management
64
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
64
Direct-Acting Cholinergic Agonists: Therapeutic Uses
712
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
712
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
236
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
236
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
426
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
426


